DiscoverThe Lancet Oncology in conversation withEmmy Boerrigter on dose selection of novel anticancer drugs
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Emmy Boerrigter on dose selection of novel anticancer drugs

Emmy Boerrigter on dose selection of novel anticancer drugs

The Lancet Group